Chemokine receptor 5 antagonist, maraviroc, does not affect the progression of aortic stenosis in hypercholesterolemic mice

Saved in:
Bibliographic Details
Published in:Atherosclerosis 2021-08, Vol.331, p.e111-e111
Main Authors: Weisell, J., Ylä-Herttuala, E., Ruotsalainen, A.-K., Laakso, H., Liimatainen, T., Rysä, J.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0021-9150
1879-1484
DOI:10.1016/j.atherosclerosis.2021.06.327